Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
663.73B
Market cap663.73B
Price-Earnings ratio
32.27
Price-Earnings ratio32.27
Dividend yield
1.90%
Dividend yield1.90%
Average volume
6.44M
Average volume6.44M
High today
$277.80
High today$277.80
Low today
$274.75
Low today$274.75
Open price
$275.00
Open price$275.00
Volume
1.90M
Volume1.90M
52 Week high
$281.07
52 Week high$281.07
52 Week low
$173.33
52 Week low$173.33

Stock Snapshot

The current Johnson & Johnson(JNJ) stock price is $275.42, with a market capitalization of 663.73B. The stock trades at a price-to-earnings (P/E) ratio of 32.27 and offers a dividend yield of 1.90%.

During the trading session on 2026-09-04, Johnson & Johnson(JNJ) shares reached a daily high of $277.80 and a low of $274.75. At a current price of $275.42, the stock is +0.2% higher than the low and still -0.9% under the high.

Trading volume for Johnson & Johnson(JNJ) stock has reached 1.9M, versus its average volume of 6.44M.

Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $281.07 and a low of $173.33.

Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $281.07 and a low of $173.33.

JNJ News

Investing.com 5h
J&J EVP Timothy Schmid sells $9.2m in company stock - Investing.com

...

J&J EVP Timothy Schmid sells $9.2m in company stock - Investing.com
24/7 Wall St. 5h
Johnson & Johnson Is Boring Which Makes Its Dividend Nearly Perfect.

Investing Johnson & Johnson Is Boring Which Makes Its Dividend Nearly Perfect. Sixty-four straight years of dividend growth sounds like a headline, but the real...

Johnson & Johnson Is Boring Which Makes Its Dividend Nearly Perfect.
Nasdaq 7h
Johnson & Johnson Reaches Analyst Target Price

In recent trading, shares of Johnson & Johnson (Symbol: JNJ) have crossed above the average analyst 12-month target price of $175.77, changing hands for $176.64...

Johnson & Johnson Reaches Analyst Target Price

Analyst ratings

69%

of 26 ratings
Buy
69.2%
Hold
26.9%
Sell
3.8%

More JNJ News

Simply Wall St 3d
Johnson & Johnson Stock May Trade At A Discount As Europe Backs Tecvayli

Johnson & Johnson stock has delivered a 3 year total return of 80.4%, yet the latest valuation checks send mixed signals, with the Discounted Cash Flow (DCF) in...

Johnson & Johnson Stock May Trade At A Discount As Europe Backs Tecvayli
24/7 Wall St. 3d
Why Procter & Gamble's Quieter Dividend Outpaces Johnson & Johnson's Growth Story

Investing Why Procter & Gamble’s Quieter Dividend Outpaces Johnson & Johnson’s Growth Story Both Johnson and Johnson and Procter & Gamble just refreshed decades...

Why Procter & Gamble's Quieter Dividend Outpaces Johnson & Johnson's Growth Story
TipRanks 4d
Stellantis appoints Stephanie Hartgrove chief communications officer

Stellantis (STLA) announced a senior leadership appointment, effective September 1. Stephanie Hartgrove has been appointed chief communications officer, reporti...

Nasdaq 6d
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Key Points AbbVie continues to expand its portfolio in high-growth areas like immunology and neuroscience. Johnson & Johnson maintains a massive footprint acr...

AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.